Skip to main content

Animations

MJFF Publications

7111 - 7120 of 8808 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2018
  • 2023
  • 2023
  • 2012
  • 2023
  • 2013
  • 2022
  • 2019
  • Summary Details
    OPEN
    Title: Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-018-0848-7
    Citation Count: 107
  • Summary Details
    OPEN
    Title: PINK 1 autophosphorylation is required for ubiquitin recognition
    Journal Name: EMBO reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.15252/embr.201744981
    Citation Count: 107
  • Summary Details
    OPEN
    Title: Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.05.020
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-45078-3
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Simultaneous Determination of the Size and Shape of Single α-Synuclein Oligomers in Solution
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acsnano.3c01393
    Citation Count: 29
  • Summary Details
    RESTRICTED
    Title: Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: Gene and smoking status interaction
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.07.007
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00526-9
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia
    Journal Name: Neuroscience Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neures.2013.10.002
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Association of Sodium–Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study
    Journal Name: Diabetes Care
    Publisher: American Diabetes Association
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2337/dc22-1705
    Citation Count: 92
  • Summary Details
    RESTRICTED
    Title: Causes and outcomes of hospitalization in Lewy body dementia: A retrospective cohort study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.03.014
    Citation Count: 28
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.